Navigation Links
Rottenstein Law Group Produces Videos to Inform Public About Paxil History, Dangers, and Litigation
Date:9/9/2011

NEW YORK, Sept. 9, 2011 /PRNewswire/ -- The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant Paxil, has produced a series of brief videos specifically intended to educate the public about the history of Paxil, possible dangers to those who take it, and litigation concerning the drug.

The Rottenstein Law Group recently launched a Paxil lawsuit resource website, www.paxilbirthdefectlaw.com, with features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, to enable visitors to spread the word about Paxil and the possible dangers of the drug. RLG has now made available at the site videos produced by the firm to educate the public. In keeping with the goal of maximum accessibility of the site, the videos can be downloaded by visitors and viewed on all manner of devices, including smart phones.

Studies have linked Paxil to numerous birth defects in children born to mothers who were taking the drug while pregnant. These include: clubbed foot; cleft lip/palate; delayed development; persistent pulmonary hypertension; gastroschisis; heart defects; skull defects; and brain/spinal cord defects. Moreover, it has been suggested that Paxil can cause premature birth or even miscarriage, and that a child exposed to Paxil in utero can experience withdrawal symptoms after birth.

About THE ROTTENSTEIN LAW GROUP

The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients in consumer product injury, mass tort, and class action lawsuits in a compassionate manner. http://www.rotlaw.com

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
1259 Veeder Drive
Hewlett NY  11557
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle@rotlaw.com
www.rotlaw.com


'/>"/>
SOURCE The Rottenstein Law Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rottenstein Law Group Heeds Groundswell of Grievances Against Manufacturers of Defective, Dangerous Hip Replacement Devices
2. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
3. Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs
4. Phalanx Biotech Group Launches microRNA Microarray - miRBase v17
5. Groupe Athena, Inc. Clarifies Previous Guidance
6. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
7. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
8. Groupe Athena, Inc. Provides Guidance on Current Orders
9. THA Group Partners with Cardiocom Telehealth
10. Global Pharm Holdings Group, Inc. Announces Second Quarter 2011 Financial Results
11. Medical Device Marketing Groups Focus More Resources on Tactical Activities When Compared to Pharmaceutical Counterparts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):